Dear Nicole,
my apologies, I was given information that Roche will no longer support the 454. Please accept my sincerest apology for the confusion.
-
Hi Aniki,
We are committed to providing our 454 instruments, parts, reagents, consumables, service and support for all our 454 products currently on the market over the next three years until mid-2016. We will also be offering new updates, including longer reads for the GS Junior System (both random fragment and amplicon libraries),
If you have any specific questions or concerns I encourage you to reach out to your local Roche service representative.
Best Regards,
Nicole
Senior Support Specialist
454 Life Sciences, A Roche CompanyLeave a comment:
-
-
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...04-04-2024, 04:25 PM -
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...03-22-2024, 06:39 AM
Leave a comment: